The city of Baltimore, Maryland, currently has 29 active clinical trials seeking participants for Healthy research studies.
Study of Healthy Cohort for Early Detection of Cancer
Recruiting
Cancer produces a significant burden on society with a majority diagnosed at late stages when the chance of cure is low. Early diagnosis improves patient outcomes. Data consisting of lifestyle factors, medications, physical activity, years before conventional cancer diagnosis is also worthwhile for to determine early detection. This is only achievable with longitudinal tracking of a large number of healthy individuals and identifying those who do develop cancer over time.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/10/2025
Locations: Johns Hopkins Hospital, Baltimore, Maryland
Conditions: Healthy
Investigation of Psychedelic Effects in Psychoactive Substances
Recruiting
The aim of this double-blind, placebo-controlled, within-subjects study is to determine whether other psychoactive substances can produce experiences akin to those seen with classic psychedelics. Screening involves a medical and psychiatric examination, including blood draw, history and physical, interviews, and questionnaires. Eligible participants will then be asked to complete up to 6 experimental drug administration session during which the participants will potentially receive and report on... Read More
Gender:
ALL
Ages:
Between 25 years and 55 years
Trial Updated:
02/05/2025
Locations: Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore, Maryland
Conditions: Psychedelic Effects in Healthy Volunteers
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Recruiting
This research study will use computerized tasks, electroencephalography (EEG), and magnetic resonance imaging (MRI) to look at how the drug psilocybin, a naturally occurring compound contained in hundreds of species of psychoactive mushrooms, changes thoughts and brain activity.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
12/16/2024
Locations: Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore, Maryland
Conditions: Healthy
Phase I Study of ICP-332 in Healthy Subjects
Recruiting
A multiple ascending dose phase I study of ICP-332 in healthy subjects
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
07/31/2024
Locations: Pharmaron CPC Inc., Baltimore, Maryland
Conditions: Healthy Subjects
A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004
Recruiting
This is a randomized, double-blind, placebo-controlled, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of a single dose of MT2004 following oral single and multiple ascending dose administration.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
02/20/2021
Locations: Pharmaron CPC, Baltimore, Maryland
Conditions: Healthy